gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Glaucoma in systemic diseases

Meeting Abstract

Search Medline for

  • corresponding author T. S. Dietlein - Zentrum für Augenheilkunde, Universität Köln, Köln-Lindenthal
  • G. K. Krieglstein - Zentrum für Augenheilkunde, Universität Köln, Köln-Lindenthal

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogDO.14.08

The electronic version of this article is the complete one and can be found online at:

Published: September 22, 2004

© 2004 Dietlein et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Systemic diseases can play a crucial role for the incidence and progression of glaucoma. Inflammatory infective or non-infective systemic diseases causing glaucoma may be often effectively treated by antibiotics or steroid or a combination of both thus limiting progression of glaucoma. However, drug-induced side effects (f.e., steroid-induced glaucoma) have to be considered. Several studies have demonstrated that diabetes mellitus and arterial hypotension are contributing risk factors to progressive glaucomatous damage in adult open-angle glaucoma. Rare congenital syndromes associated with glaucoma display different mechanisms of intraocular pressure increase. There are closed-angle glaucomas in microphthalmia (Hallermann-Streiff), pupillary block situations in spherophakia (Weill-Marchesani) or different mechanisms as in Marfan´s syndrome. Management of these patients in specialized tertiary centres seems justified.